Moderna’s COVID-19 vaccine shows early promise; shares soarAntibodies, Biotechnology, Business, Clinical Data, Clinical Trials, Coronavirus Disease (COVID-19) Pandemic, Coronavirus Vaccines, R&D, Scientists, Shares, U.S. National Institute of Allergy and Infectious DiseaseEarly data from Moderna Inc.’s COVID-19 vaccine – the first to be tested in the United States – showed that it produced protective antibodies in a small group of healthy volunteers, the company said. Read more May 18, 2020/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/05/U.N.-calls-for-COVID-vaccine-treatment-available-for-all-Reuters-5-4-20.jpeg 684 1100 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2020-05-18 10:30:222020-05-22 02:21:33Moderna’s COVID-19 vaccine shows early promise; shares soar